Recovery from Experimental Parkinsonism in Primates with GM 1 Ganglioside Treatment-Reference-Cited by-同舟云学术

Recovery from Experimental Parkinsonism in Primates with GM 1 Ganglioside Treatment

Published:1992-05-08 Issue:5058 Volume:256 Page:843-846
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Schneider J. S.¹,Pope A.¹,Simpson K.¹,Taggart J.¹,Smith M. G.¹,DiStefano L.¹

Affiliation:

1. Center for Neurological Research, Department of Neurology, and Institute of Neuroscience, Hahnemann University School of Medicine, Philadelphia, PA 19102.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference36 articles.

1. AGNATI, L.F., GANGLIOSIDES INCREASE THE SURVIVAL OF LESIONED NIGRAL DOPAMINE NEURONS AND FAVOR THE RECOVERY OF DOPAMINERGIC SYNAPTIC FUNCTION IN STRIATUM OF RATS BY COLLATERAL SPROUTING, ACTA PHYSIOLOGICA SCANDINAVICA 119: 347 (1983).

2. DIAMOND, A, DEVELOPMENTAL TIME COURSE IN HUMAN INFANTS AND INFANT MONKEYS, AND THE NEURAL BASES OF, INHIBITORY CONTROL IN REACHING, ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 608: 637 (1990).

3. ELSWORTH, J.D., EFFECTS OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) ON CATECHOLAMINES AND METABOLITES IN PRIMATE BRAIN AND CSF, BRAIN RESEARCH 415: 293 (1987).

4. FALARDEAU, P, RELATION BETWEEN BRAIN DOPAMINE LOSS AND D2 DOPAMINE RECEPTOR DENSITY IN MPTP MONKEYS, NEUROSCIENCE LETTERS 86: 225 (1988).

5. GHIDONI, R, UPTAKE, CELL PENETRATION AND METABOLIC PROCESSING OF EXOGENOUSLY ADMINISTERED GM1 GANGLIOSIDE IN RAT-BRAIN, NEUROCHEMISTRY INTERNATIONAL 15: 455 (1989).

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioactive sphingolipids as emerging targets for signal transduction in cancer development;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. Multi-Omic Analysis Reveals Lipid Dysregulation Associated with Mitochondrial Dysfunction in Parkinson’s Disease Brain;2024-07-22

3. Glycosphingolipids and central nervous system–related diseases;Glycosphingolipids in the Central Nervous System;2024

4. Ganglioside GM1 and the Central Nervous System;International Journal of Molecular Sciences;2023-05-31

5. COX-2 as the key target of LianXia NingXin Formula for treating Sympathetic Remodeling after Myocardial Infarction: pharmacological network prediction with experimental validation;2021 IEEE International Conference on Bioinformatics and Biomedicine (BIBM);2021-12-09